These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23066863)

  • 1. Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment.
    Dialla PO; Dabakuyo TS; Marilier S; Gentil J; Roignot P; Darut-Jouve A; Poillot ML; Quipourt V; Arveux P
    BMC Cancer; 2012 Oct; 12():472. PubMed ID: 23066863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.
    Dabakuyo TS; Bonnetain F; Roignot P; Poillot ML; Chaplain G; Altwegg T; Hedelin G; Arveux P
    Ann Oncol; 2008 Feb; 19(2):276-83. PubMed ID: 17962200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors determining the choice between mastectomy and conservative treatment in the Côte-d'Or department (France). The Côte-d'Op6 register of gynecological cancers].
    Chaplain G; Barillot I; Cuisenier J; Milan C; Collin F; Dusserre P; Michiels R; Le Dorze C
    Bull Cancer; 1994 Apr; 81(4):303-10. PubMed ID: 7703547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In breast cancer, are treatments and survival the same whatever a patient's age? A population-based study over the period 1998-2009.
    Dialla PO; Quipourt V; Gentil J; Marilier S; Poillot ML; Roignot P; Altwegg T; Darut-Jouve A; Guiu S; Arveux P; Dabakuyo-Yonli TS
    Geriatr Gerontol Int; 2015 May; 15(5):617-26. PubMed ID: 25110068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors.
    Dabakuyo TS; Dialla O; Gentil J; Poillot ML; Roignot P; Cuisenier J; Arveux P
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):809-16. PubMed ID: 22642448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based study.
    Dabakuyo TS; Arnaud A; Maingon P; Causeret S; Coudert B; Fumoleau P; Arnould L; Poillot ML; Arveux P; Crehange G; Bonnetain F
    Eur J Cancer Care (Engl); 2013 Sep; 22(5):638-47. PubMed ID: 23647444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
    Goldberg M; Sutradhar R; Paszat L; Whelan TJ; Gu S; Fong C; Rakovitch E
    Breast Cancer Res Treat; 2019 Aug; 176(3):657-667. PubMed ID: 31076954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].
    Coudert B; Chaplain G; Milan C; Janoray P
    Bull Cancer; 1996 Jan; 83(1):54-62. PubMed ID: 8672857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.
    Hamidou Z; Causeret S; Dabakuyo TS; Gentil J; Arnould L; Roignot P; Altwegg T; Poillot ML; Bonnetain F; Arveux P
    BMC Cancer; 2010 Nov; 10():622. PubMed ID: 21067600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of geriatric oncology consultation on the management of breast cancer in older women: a French population-based study.
    Somana-Ehrminger S; Dabakuyo TS; Manckoundia P; Ouédraogo S; Marilier S; Arveux P; Quipourt V
    Geriatr Gerontol Int; 2015 Jan; 15(1):111-9. PubMed ID: 24456152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer of the breast in Cote-d'Or (1982-1987). The Burgundian register of gynecologic diseases].
    Chaplain G; Cuisenier J; Le Dorze C; Pansiot F; Bastien H
    Bull Cancer; 1990; 77(1):5-14. PubMed ID: 2317576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related socio-economic and geographic disparities in breast cancer stage at diagnosis: a population-based study.
    Dialla PO; Arveux P; Ouedraogo S; Pornet C; Bertaut A; Roignot P; Janoray P; Poillot ML; Quipourt V; Dabakuyo-Yonli TS
    Eur J Public Health; 2015 Dec; 25(6):966-72. PubMed ID: 25829506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
    Yancik R; Wesley MN; Ries LA; Havlik RJ; Edwards BK; Yates JW
    JAMA; 2001 Feb; 285(7):885-92. PubMed ID: 11180731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
    Smith-Graziani D; Lei X; Giordano SH; Zhao H; Karuturi M; Chavez-MacGregor M
    Cancer Med; 2020 Oct; 9(19):6961-6971. PubMed ID: 32767723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: A population-based cohort study.
    Jauhari Y; Dodwell D; Gannon MR; Horgan K; Clements K; Medina J; Cromwell DA
    Eur J Surg Oncol; 2021 Feb; 47(2):251-260. PubMed ID: 33268213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer.
    Samman S; Cornacchi SD; Foster G; Thabane L; Thomson S; Lovrics O; Martin S; Lovrics PJ
    Am J Surg; 2021 Aug; 222(2):361-367. PubMed ID: 33358573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapeutic decisions in elderly breast cancer patients: the role of chemotherapy in a retrospective analysis.
    Jueckstock J; Kasch F; Jaeger B; Schramm A; Janni W; Scholz C
    Arch Gynecol Obstet; 2015 Nov; 292(5):1101-7. PubMed ID: 25935195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.